Publications by authors named "Adel Alharf"

Claim this Profile
A
A survey of regulatory recommendations for waivers of bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2.
Alfredo García-Arieta, Andrew Tam, Florencia Tiseyra, Eduardo Agostinho Freitas Fernandes, Kelen Carine Costa Soares, Adel Alharf

J Pharm Pharm Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug Authority.
Omaima O Arab, Mohammed Aldayan, Khalid Almowaizri, Ahmad Alghamdi, Jahad Alghamdi, Adel Alharf

Ther Innov Regul Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example.
Alhanouf Yousef Alnafisah, Ahmed Fawaz Alkhalidi, Hanin Aljohani, Manal Almutairi, Adel Alharf

Clin Epidemiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities.
Eduardo Agostinho Freitas Fernandes, Joy van Oudtshoorn, Andrew Tam, Liliana Carolina Arévalo González, Erwin Guzmán Aurela, Adel Alharf

J Pharm Pharm Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).
Maha Al Ammari, Bader Almuzzaini, Khalid Al Sulaiman, Mohammed AlBalwi, Khizra Sultana, Adel Alharf

Pharmacogenomics J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National medicines policy development, Saudi Arabia.
Khalid Almoteiry, Adel Alharf, Bandar Al Hammad, Ibrahim Aljuffali, Nahar Al-Azemi

Bull World Health Organ· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure-lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials.
Jahad Alghamdi, Abdulziz Alqadi, Adel Alharf, Bader Almuzzaini, Azra Mahmud

Eur J Clin Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saudi Vigilance Program: Challenges and lessons learned.
Adel Alharf, Nasser Alqahtani, Ghazi Saeed, Ali Alshahrani, Mubarak Alshahrani

Saudi Pharm J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top 10 most used drugs in the Kingdom of Saudi Arabia 2010-2015.
Osama A AlKhamees, Khaled A AlNemer, Mohammed W Bin Maneea, Faisal A AlSugair, Bassam H AlEnizi, Adel A Alharf

Saudi Pharm J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis